Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine Infusion Doses in Obese Patients Undergoing Laparoscopic Cancer Surgery
NCT04730375Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Jan 2021
- Primary completion
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dexmedetomidine, sponsored by National Cancer Institute. Started Jan 2021; status: completed.
02
Drugs
dexmedetomidine
Beyond the preview
Go deeper on NCT04730375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04730375.